Phase I Study of Cisplatin Plus OSI-7904L in Patients With Solid Tumors

NCT00116896 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: OSI-7904L
DRUG: Cisplatin

Sponsor

OSI Pharmaceuticals